These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8868127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs.
    Hendset M, Haslemo T, Rudberg I, Refsum H, Molden E.
    Pharmacopsychiatry; 2006 Jul; 39(4):121-7. PubMed ID: 16871467
    [Abstract] [Full Text] [Related]

  • 3. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly.
    Shulman RW, Ozdemir V.
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124
    [Abstract] [Full Text] [Related]

  • 4. Metabolic drug interactions with newer antipsychotics: a comparative review.
    Spina E, de Leon J.
    Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):4-22. PubMed ID: 17214606
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL, Gill HS.
    J Clin Psychiatry; 1997 Jan; 58 Suppl 5():7-14. PubMed ID: 9184622
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A, Gonnier V, Aussilloux C.
    Encephale; 2002 Jan; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [Abstract] [Full Text] [Related]

  • 9. The significance of pharmacodynamic measurements in the assessment of bioavailability and bioequivalence of psychotropic drugs using CEEG and dynamic brain mapping.
    Itil TM, Itil KZ.
    J Clin Psychiatry; 1986 Sep; 47 Suppl():20-7. PubMed ID: 3528132
    [Abstract] [Full Text] [Related]

  • 10. Basic pharmacokinetic principles and their application to psychotropic drugs.
    Greenblatt DJ.
    J Clin Psychiatry; 1993 Sep; 54 Suppl():8-13; discussion 55-6. PubMed ID: 8407859
    [Abstract] [Full Text] [Related]

  • 11. A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs.
    Linnet K, Ejsing TB.
    Eur Neuropsychopharmacol; 2008 Mar; 18(3):157-69. PubMed ID: 17683917
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacologic interactions of antibiotics and psychotropic drugs].
    Joos AA.
    Psychiatr Prax; 1998 Mar; 25(2):57-60. PubMed ID: 9577846
    [Abstract] [Full Text] [Related]

  • 13. Formation of active metabolites of psychotropic drugs. An updated review of their significance.
    Caccia S, Garattini S.
    Clin Pharmacokinet; 1990 Jun; 18(6):434-59. PubMed ID: 2191820
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
    Melzacka M.
    Pol J Pharmacol Pharm; 1984 Jun; 36(2-3):117-36. PubMed ID: 6147827
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metabolic drug interactions with new psychotropic agents.
    Spina E, Scordo MG, D'Arrigo C.
    Fundam Clin Pharmacol; 2003 Oct; 17(5):517-38. PubMed ID: 14703714
    [Abstract] [Full Text] [Related]

  • 17. Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
    Greenblatt DJ, von Moltke LL, Harmatz JS, Ciraulo DA, Shader RI.
    J Clin Psychiatry; 1993 Oct; 54 Suppl():4-11; discussion 12-4. PubMed ID: 8262889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pharmacokinetic aspects of therapy with psychotropic agents.
    Kaumeier S.
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):27-31. PubMed ID: 631968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.